ProFunds Biotechnology UltraSector Fund Investor Class (BIPIX)

Fund Assets	132.73M
Expense Ratio	1.52%
Min. Investment	$15,000
Turnover	52.00%
Dividend (ttm)	0.23
Dividend Yield	0.24%
Dividend Growth	116.61%
Payout Frequency	n/a
Ex-Dividend Date	Dec 30, 2025

Previous Close	91.33
YTD Return	35.71%
1-Year Return	99.27%
5-Year Return	12.97%
52-Week Low	45.99
52-Week High	105.85
Beta (5Y)	1.13
Holdings	157
Inception Date	Jun 19, 2000

About BIPIX

The ProFunds Biotechnology UltraSector Fund Investor Class is a leveraged mutual fund focused on the biotechnology sector of the U.S. equity market. Its primary objective is to achieve daily investment results that correspond to 1.5 times the daily performance of the S&P Biotechnology Select Industry Index. This index measures the performance of biotechnology companies within the S&P Total Market Index. The fund employs financial instruments and derivatives to amplify its exposure to biotechnology stocks, making it a non-diversified fund with a portfolio that typically includes around 146 holdings. Founded in 2000, the fund targets growth and value stocks across various market capitalizations within healthcare, pharmaceuticals, biotech, and life sciences industries. It serves as a specialized investment vehicle designed to provide leveraged exposure to the biotechnology sector, catering to investors seeking amplified returns linked to the daily movements of biotechnology equities. The fund’s expense ratio stands at approximately 1.56%, and it distributes dividends semi-annually. Its role in the financial markets lies in catering to active traders and investors who want leveraged sector exposure within biotechnology.

• Fund Family: ProFunds
• Category: Trading--Leveraged Equity
• Performance Rating: Above Average
• Risk Rating: High
• Stock Exchange: NASDAQ
• Ticker Symbol: BIPIX
• Share Class: Investor Class
• Index: Dow Jones US Biotechnology TR

Performance

BIPIX had a total return of 99.27% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.99%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
BIPSX	Service Class	2.52%

Top 10 Holdings

35.62% of assets

Name	Symbol	Weight
HSBC SECURITIES (USA), INC. B 3.5 , 5/01/2026	n/a	8.47%
SOCIETE' GENERALE 3.52 , 5/01/2026	n/a	7.20%
CF Secured 3.52 , 5/01/2026	n/a	6.36%
NATWEST MARKETS PLC 3.51 , 5/01/2026	n/a	4.24%
UMB FINANCIAL CORP. 3.37 , 5/01/2026	n/a	2.11%
Invesco Shrt-Trm Inv Gov&Agcy Instl	AGPXX	2.05%
ROYAL BANK OF CANADA 3.42 , 5/01/2026	n/a	1.48%
Apellis Pharmaceuticals, Inc.	APLS	1.35%
Revolution Medicines, Inc.	RVMD	1.19%
Travere Therapeutics, Inc.	TVTX	1.17%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 30, 2025	$0.22675	Dec 31, 2025
Dec 19, 2025	$0.01967	Dec 22, 2025
Dec 31, 2024	$0.10468	Jan 2, 2025
Dec 27, 2024	$13.04498	Dec 30, 2024
Dec 20, 2023	$4.12801	Dec 21, 2023
Dec 21, 2020	$8.0736	Dec 21, 2020

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Sep 18, 2026

Data Sources Report a data error